KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 79 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $801,000 | +6.0% | 51,757 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $756,000 | -22.9% | 51,757 | 0.0% | 0.01% | -16.7% |
Q2 2020 | $980,000 | -44.2% | 51,757 | -43.4% | 0.01% | -50.0% |
Q1 2020 | $1,756,000 | +85.6% | 91,406 | -9.4% | 0.01% | +200.0% |
Q4 2018 | $946,000 | -47.2% | 100,921 | -4.0% | 0.00% | -42.9% |
Q3 2018 | $1,791,000 | -54.7% | 105,172 | -54.8% | 0.01% | -56.2% |
Q2 2018 | $3,954,000 | +96.4% | 232,713 | +55.1% | 0.02% | +100.0% |
Q1 2018 | $2,013,000 | +42.8% | 150,022 | +2.1% | 0.01% | +60.0% |
Q4 2017 | $1,410,000 | +64.0% | 146,918 | +87.6% | 0.01% | +66.7% |
Q3 2017 | $860,000 | +54.1% | 78,307 | +27.1% | 0.00% | +50.0% |
Q2 2017 | $558,000 | +2225.0% | 61,622 | +3306.4% | 0.00% | – |
Q4 2015 | $24,000 | 0.0% | 1,809 | -20.6% | 0.00% | – |
Q3 2015 | $24,000 | -25.0% | 2,279 | +145.1% | 0.00% | – |
Q3 2014 | $32,000 | -25.6% | 930 | 0.0% | 0.00% | – |
Q2 2014 | $43,000 | +43.3% | 930 | -4.9% | 0.00% | – |
Q1 2014 | $30,000 | – | 978 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management I, LLC | 999,275 | $37,403,000 | 55.08% |
New Leaf Venture Partners, L.L.C. | 126,687 | $4,742,000 | 2.31% |
Cormorant Asset Management, LP | 385,000 | $14,411,000 | 2.22% |
SECTORAL ASSET MANAGEMENT INC | 529,920 | $19,835,000 | 0.89% |
PFM Health Sciences, LP | 850,337 | $31,828,000 | 0.74% |
Partner Investment Management, L.P. | 16,399 | $614,000 | 0.25% |
Tekla Capital Management LLC | 137,766 | $5,157,000 | 0.24% |
Candriam S.C.A. | 298,000 | $11,154,000 | 0.23% |
Eventide Asset Management | 30,000 | $1,123,000 | 0.12% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 81,047 | $3,034,000 | 0.12% |